A lower-dose maintenance attempt is a practical translation supported by directional real-world evidence, not a trial-proven protocol
It inhibits growth but does not sterilize
This distinction matters when switching between peptides or when researchers accidentally apply semaglutide calculation logic to retatrutide, a common and potentially significant mistake
Combining these with a KPV spray adds NF-B-mediated anti-inflammatory coverage creating a three-peptide gut protocol addressing inflammation (KPV), vascular repair (BPC-157), and cellular repair mechanics (TB-500)
PRP delivers concentrated growth factors directly to injury sites with stronger clinical trial evidence especially for tendon injuries and mild knee arthritis BPC-157 works systemically through VEGF upregulation and nitric oxide modulation with strong animal data but limited large-scale human trials What it may miss It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation